We evaluated the anticancer effects of ascorbate either alone or in combination with the anti-mouse PD1 antibody J43 in a syngeneic C57BL/6NCrl melanoma model and elucidated the modifications of the tumor immune microenvironment. This evidence concerns the gene PDCD1 and neoplasm.